Literature DB >> 30740218

Copper salt-catalyzed formation of a novel series of triazole-spirodienone conjugates with potent anticancer activity.

Linghui Gu1, Peng Wang1, Qiu Zhong2,3, Yuxing Deng1, Jiangping Xie1, Fei Liu1, Fan Xiao4, Shilong Zheng2,3, Yue Chen5, Guangdi Wang2,3, Ling He1.   

Abstract

Copper salt-catalyzed oxidative amination resulted in the formation of a novel series of triazole- spirodienone conjugates, 4-triazolyl-1-oxa-4-azaspiro[4,5]deca-6,9-dien-3,8-diones and 4-triazolyl-1-oxa-4-azaspiro[4,5]deca-6,9-dien-8-ones. A single crystal of compound 1p among them was grown and analyzed by X-ray crystallography. These compounds were evaluated for their antiproliferative activities against MDA-MB-231, HeLa, A549 and MCF-7 cell lines. Most of them showed moderate to high anticancer potency in the four cancer cell lines. The discovery of the triazole-spirodienone conjugates as cytotoxic agents against cancer cells may open up a new field in which these novel small molecules could be further explored as promising anticancer agents.

Entities:  

Year:  2017        PMID: 30740218      PMCID: PMC6364840          DOI: 10.1039/C6RA24764D

Source DB:  PubMed          Journal:  RSC Adv        ISSN: 2046-2069            Impact factor:   3.361


  31 in total

1.  Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Olga Cruz-Lopez; Carlota Lopez Cara; Maria Dora Carrion; Andrea Brancale; Ernest Hamel; Longchuan Chen; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

2.  Chemistry and biology of deoxynyboquinone, a potent inducer of cancer cell death.

Authors:  Joseph S Bair; Rahul Palchaudhuri; Paul J Hergenrother
Journal:  J Am Chem Soc       Date:  2010-04-21       Impact factor: 15.419

3.  Synthesis and evaluation of quinonoid compounds against tumor cell lines.

Authors:  Eufrânio N da Silva; Bruno C Cavalcanti; Tiago T Guimarães; Maria do Carmo F R Pinto; Igor O Cabral; Cláudia Pessoa; Letícia V Costa-Lotufo; Manoel O de Moraes; Carlos K Z de Andrade; Marcelo R Dos Santos; Carlos A de Simone; Marilia O F Goulart; Antonio V Pinto
Journal:  Eur J Med Chem       Date:  2010-11-09       Impact factor: 6.514

4.  Copper-catalyzed synthesis of azaspirocyclohexadienones from alpha-azido-N-arylamides under an oxygen atmosphere.

Authors:  Shunsuke Chiba; Line Zhang; Jian-Yuan Lee
Journal:  J Am Chem Soc       Date:  2010-06-02       Impact factor: 15.419

5.  First hypervalent iodine(III)-catalyzed C-N bond forming reaction: catalytic spirocyclization of amides to N-fused spirolactams.

Authors:  Toshifumi Dohi; Akinobu Maruyama; Yutaka Minamitsuji; Naoko Takenaga; Yasuyuki Kita
Journal:  Chem Commun (Camb)       Date:  2006-12-22       Impact factor: 6.222

6.  Identification of CKD-516: a potent tubulin polymerization inhibitor with marked antitumor activity against murine and human solid tumors.

Authors:  Jaekwang Lee; Soo Jin Kim; Hojin Choi; Young Hoon Kim; In Taek Lim; Hyun-mo Yang; Chang Sik Lee; Hee Ryong Kang; Soon Kil Ahn; Seung Kee Moon; Dal-Hyun Kim; Sungsook Lee; Nam Song Choi; Kyung Joo Lee
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

7.  Highly efficient cyanoimidation of aldehydes.

Authors:  Ping Yin; Wen-Bo Ma; Yue Chen; Wen-Cai Huang; Yong Deng; Ling He
Journal:  Org Lett       Date:  2009-12-03       Impact factor: 6.005

Review 8.  History of aromatase: saga of an important biological mediator and therapeutic target.

Authors:  R J Santen; H Brodie; E R Simpson; P K Siiteri; A Brodie
Journal:  Endocr Rev       Date:  2009-04-23       Impact factor: 19.871

9.  Cribrostatin 6 induces death in cancer cells through a reactive oxygen species (ROS)-mediated mechanism.

Authors:  Mirth T Hoyt; Rahul Palchaudhuri; Paul J Hergenrother
Journal:  Invest New Drugs       Date:  2010-02-20       Impact factor: 3.850

10.  Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.

Authors:  Catriona Parker; Rachel Waters; Carly Leighton; Jeremy Hancock; Rosemary Sutton; Anthony V Moorman; Philip Ancliff; Mary Morgan; Ashish Masurekar; Nicholas Goulden; Nina Green; Tamas Révész; Philip Darbyshire; Sharon Love; Vaskar Saha
Journal:  Lancet       Date:  2010-12-03       Impact factor: 79.321

View more
  3 in total

1.  Taguchi-Assisted Optimization Technique and Density Functional Theory for Green Synthesis of a Novel Cu-MOF Derived From Caffeic Acid and Its Anticancerious Activities.

Authors:  Malihe Zeraati; Ali Mohammadi; Somayeh Vafaei; Narendra Pal Singh Chauhan; Ghasem Sargazi
Journal:  Front Chem       Date:  2021-11-26       Impact factor: 5.221

2.  Porous Cu-MOF nanostructures with anticancer properties prepared by a controllable ultrasound-assisted reverse micelle synthesis of Cu-MOF.

Authors:  Reza Akhavan-Sigari; Malihe Zeraati; Mohammadreza Moghaddam-Manesh; Parya Kazemzadeh; Sara Hosseinzadegan; Narendra Pal Singh Chauhan; Ghasem Sargazi
Journal:  BMC Chem       Date:  2022-03-05

3.  Novel synthesis of divergent aryl imidazoles from ketones involving copper-catalyzed α-amination and oxidative C-C bond cleavage.

Authors:  Jiangkun Huang; Lan Luo; Naiguo Xing; Linghui Gu; Chen Li; Qiao Han; Shilong Zheng; Ling He
Journal:  RSC Adv       Date:  2020-04-06       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.